Answer
Yes, polatuzumab vedotin (Polivy) is contraindicated in patients with active severe infections.
Sources for this answer
- Polivy 30 mg and 140 mg powder for concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked